Mixed results were announced on Sunday from another Phase III trial comparing prasugrel and Plavix among patients with acute coronary syndrome who were planning to receive stents.

• 之前在周日公布的三期临床试验的混杂结果对比了在打算安装支架的急性冠脉综合征患者身上普拉格雷和Plavix的作用。